Improving Efficiency and Power in Small Rare-Disease Trials Through Prespecified, Data-Adaptive Covariate Adjustment
stat.ME
Submitted: 2026-11-11
Updated: 2026-11-11
Terminology
Sources
- Investigating Targeting Strategies and Truncation in TMLE for the Average Treatment Effect under Practical Positivity Violations
- A CV-TMLE global test approach to improve power in rare disease clinical studies with multiple-component endpoints
Related papers
- Learning Robust Treatment Rules for Censored Data
- Neural Estimation of Summary Statistics for Simulation-Based Inference with Non-Asymptotic Guarantees
- Spectral divide-and-conquer MCMC for long stationary time series
- Improving the Efficiency of Subgroup Analysis in Randomized Controlled Trials with TMLE
- Personalized Federated Vector Autoregression with Personalization Diversity
- Doubly Robust and Efficient Calibration of Prediction Sets for Right-Censored Time-to-Event Outcomes